You are here: Industry Insights > PAREXEL

News List

Pharma industry reports 75 deals worth $26.6 billion in July 2021: GlobalData expresspharma
August 09, 2021
The industry also reported 112 venture capital (VC) deals worth $3.8 billion in the same month.
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcomes prnasia
July 20, 2021
Based on its recent analysis of the global clinical research organization (CRO) market, Frost & Sullivan recognizes leading global CRO Parexel with the 2021 Global Enabling Technology Leadership Award.
EQT Private Equity and Goldman Sachs to acquire Parexel expresspharma
July 05, 2021
Parexel, a global clinical research organisation (CRO), announced the execution of a definitive merger agreement under which it will be acquired by EQT IX fund (EQT Private Equity) and the private equity business within Goldman Sachs Asset Management ...
Parexel Said to Draw Interest From AmerisourceBergen, PE Firms firstwordpharma
June 25, 2021
According to people familiar with the matter, pharmaceutical services company Parexel has drawn interest from suitors including AmerisourceBergen, Bloomberg reported.
Parexel and NeoGenomics announce partnership to improve clinical trials expresspharma
February 25, 2021
The companies will collaborate to optimise study designs and speed up patient matching in oncology clinical trials.
Parexel Completes Strategic Separation contractpharma
January 13, 2021
Parexel, a provider of drug development servicess from clinical through commercialization, has completed the separation of its Parexel Informatics and Medical Imaging business.
Parexel Appoints Chief Patient Officer contractpharma
January 07, 2021
Parexel, a provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, has appointed Clare Grace, Ph.D., as the company’s first chief patient officer.
Parexel Acquires Roam Analytics’ NLP Capability contractpharma
September 24, 2020
Expands capabilities in Artificial Intelligence and Machine Learning to further streamline and extract insights from unstructured data.
Parexel, Pfizer Extend Long-Term Partnership contractpharma
August 28, 2020
Parexel will provide clinical development services via full-service, hybrid and functional service provider (FSP) models across all therapeutic areas.
COVID-19 has made effective use of data in clinical development even more critical expresspharma
May 20, 2020
Parexel has deployed at-home care and monitoring as well as delivered supplies and drug products Direct-to-Patient to minimise the impact of the Covid-19 pandemic on ongoing clinical trials, says Sanjay Vyas, Parexel’s Senior Vice President ...

Previous page 1 2 3 Next page